1 / 6

Neuroleptics Market Global Production, Growth, Share, Demand and Applications Forecast to 2027

The Global Neuroleptics Market Report is an extensive and comprehensive document comprising details on business strategies, qualitative and quantitative analysis of the market on global and regional levels

ajaychandak01
Download Presentation

Neuroleptics Market Global Production, Growth, Share, Demand and Applications Forecast to 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Neuroleptics Neuroleptics Market To Reach Market To Reach USD 15.41 Billion USD 15.41 Billion By By 2027 2027

  2. Market Market Summary Summary Market Size – USD 13.31 Billion in 2018, Market Growth - CAGR of 1.8%, Market Trends – The increase in predominance of mental disorders in various parts of the region is fuelling the market growth. The global Neuroleptics Market is estimated to reach USD 15.41 Billion by 2026, according to a new report by Reports and Data. This can be mainly associated with the rising incidence of psychosis and other related diseases. The major factors responsible for the rising incidence of these disorders include substance-induced psychoses, genetic mutations, and physical illness that lead to depression. Growing drug abuse, addiction to Neuroleptics drugs and over prescription of drugs are also some of the notable factors that are contributing to the growth of the market. Additional factors such as high investments in research and development and the introduction of new and developed Neuroleptics compounds are expected to stimulate the market growth further.

  3. Market Market Summary Summary Anti-psychotic drugs, also called neuroleptics or tranquilizers, are a particular type of medication that is used for treating schizophrenia or bipolar disorder mostly. They are used to treat psychosis, including delusions, hallucinations, and disordered thought of paranoia, among others. These drugs prevent the dopamine receptors in the dopaminergic pathways of the brain, by controlling the effect of dopamine, which is directly connected to the psychotic encounters. The growing predominance of mental illness meanwhile has led to massive consumption of Neuroleptics. National Alliance of Mental Illness conducted a research in 2015 which says, 1 in 5 adults is experiencing mental issues. However, use of these drugs for a long time can result in side effects like involuntary movement disorder and metabolic syndrome, eventually leading to rising mortality in the population with dementia. North America accounts for the largest market share of 22.30% in 2018. It is expected to grow at a CAGR of 1.8% during the forecast period. Many people with physical disorders suffer from co-occurring disorders. An increasing predominance of mental health disorders, such as bipolar disorder and schizophrenia, is driving the growth of the Neuroleptics market in North America. Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1282

  4. Market Market Summary Summary Key market players include AstraZeneca, GlaxoSmithKline, Eli Lilly, Johnson & Johnson, Alkermes, Actavis Generics, Bristol-Myers Squibb, Allergen, Otsuka and Pfizer Furthermore, the report segments the market on the basis of types, applications, and key geographical regions. End User Outlook (Volume, Kilo Tons; and Revenue, USD Million; 2016-2027) • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies Product Outlook (Volume, Kilo Tons; and Revenue, USD Million; 2016-2027) • First-generation Drugs • Second-generation Drugs • Third-generation Drugs To know more about the report, visit @ https://www.reportsanddata.com/report-detail/neuroleptics- market

  5. Market Market Summary Summary Further key findings from the report suggest Disease Outlook (Volume, Kilo Tons; and Revenue, USD Million; 2016-2027) • Schizophrenia • Unipolar Depression • Bipolar Disorder • Dementia • Others Regional Outlook (Revenue, USD Million; 2017-2027) North America U.S Canada Mexico Europe Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1282

  6. About US About US Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact US Contact US John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related